Clinical Trials Browser

Unknown × endostar protein × Thoracic × Clear all

NCT05203276 2023-06-22

Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLC

Phase 2 Unknown

Lung Neoplasms

NCT05574998 2022-10-12

FTANLCNDG

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05529355 2022-09-07

Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT04942301 2021-06-30

PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy

Phase 1 Unknown

Carcinoma, Non-Small-Cell Lung

NCT04613284 2020-11-03

RELIEF

Phase 4 Unknown

Lung Neoplasms

NCT04274270 2020-03-19

SBRTLCES

Phase NA Unknown

Lung Neoplasms, Radiation Injuries

NCT04303130 2020-03-10

Camrelizumab Combined With Endostar for First-line Treatment in Subjects With Advanced Squamous NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT03706703 2018-10-17

Rh-Endostatin (Endostar®) Continuous Intravenous Infusion

Phase 2 Unknown

Lung Neoplasms

NCT03614065 2018-08-03

Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT03123445 2017-04-21

Endostar First-line Treatment of Advanced NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02579564 2016-10-21

Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02804646 2016-06-21

Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma

Phase 4 Unknown

Adenocarcinoma of Lung

NCT02513355 2015-08-04

Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02375022 2015-03-24

Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations

Phase 2 Unknown

Lung Neoplasms

NCT02350361 2015-01-29

Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance.

Phase 2/3 Unknown

Lung Neoplasms

NCT02005120 2013-12-20

Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02001168 2013-12-04

Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠB

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01218594 2012-10-17

DP-EN-RT

Phase 2 Unknown

50 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung

NCT00657423 2010-09-17

Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC)

Phase 3 Unknown

Lung Neoplasms

NCT01158144 2010-07-08

Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01028729 2009-12-09

NSCLC

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung